Tag: Techcrunch

August 14, 2020

Today, we’re excited to announce that Mighty Capital portfolio company, Mission Bio has raised a new $70 million Series C funding round, led by Novo Growth and including participation from Soleus Capital and existing investors Mayfield, Cota and Agilent. Mission Bio will use the funding to scale its Tapestri Platform, which uses the company’s work in single-cell multi-omics technology to help optimize clinical trials for targeted, precision cancer therapies.

Read More

© 2020 Mighty Capital All Rights Reserved